Federal · United StatesCloses Jan 7, 2027 · 80 days
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Department of Health and Human Services · PAR-25-026
AwardAmount not stated
DeadlineJan 7, 2027
PostedDec 5, 2024
What it funds
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children.
Who can apply
For profit organizations other than small businesses; Small businesses; Independent school districts; Special district governments. Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-b
HealthGrant
View on Grants.gov
Source: Grants.gov, checked Oct 19, 2026. Deadlines change; the funder's page wins.